Podcast

The Readout Loud

Author: STAT
Feed episode count: 414
Official site: https://soundcloud.com/readout-loud
RSS: https://feeds.megaphone.fm/thereadoutloud
JSON: /v1/public/podcasts/the-readout-loud-1134305
Markdown: /podcast/the-readout-loud-1134305.md

Summary

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Episodes

Jul 16, 2026 · not_requested

409: Predicting biotech clinical trials & a new Alzheimer's drug controversy

Duration seconds: 2132
Source: https://traffic.megaphone.fm/TTSAA9068866669.mp3

HTML Markdown JSON

Jul 9, 2026 · not_requested

408: Whistleblower takes on health insurance and FDA commissioner candidates

Duration seconds: 2638
Source: https://traffic.megaphone.fm/TTSAA2387995576.mp3

HTML Markdown JSON

Jun 25, 2026 · not_requested

407: The mysterious case of Eli Lilly's obesity drug

Duration seconds: 2565
Source: https://traffic.megaphone.fm/TTSAA8014095271.mp3

HTML Markdown JSON

Jun 18, 2026 · not_requested

406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises

Duration seconds: 2170
Source: https://traffic.megaphone.fm/TTSAA4011922611.mp3

HTML Markdown JSON

Jun 11, 2026 · not_requested

405: An obesity drug deep-dive, and peptides move mainstream

Duration seconds: 2186
Source: https://traffic.megaphone.fm/TTSAA8579876573.mp3

HTML Markdown JSON

Jun 4, 2026 · not_requested

404: What RevMed's pancreatic cancer drug meant for one patient

Duration seconds: 2269
Source: https://traffic.megaphone.fm/TTSAA4075545052.mp3

HTML Markdown JSON

May 28, 2026 · not_requested

403: Biotech exec Jeremy Levin on the industry's strategic turning point

Duration seconds: 2842
Source: https://traffic.megaphone.fm/TTSAA7370303095.mp3

HTML Markdown JSON

May 21, 2026 · not_requested

402: Guarding biotech from China and big bets in longevity

Duration seconds: 2648
Source: https://traffic.megaphone.fm/TTSAA3656178567.mp3

HTML Markdown JSON

May 14, 2026 · not_requested

401: Makary’s departure and Cassidy’s tenuous Senate seat

Duration seconds: 2443
Source: https://traffic.megaphone.fm/TTSAA2873727963.mp3

HTML Markdown JSON

May 7, 2026 · not_requested

400: Seaport's IPO adventure, obesity pill battles, and Makary's troubles

Duration seconds: 1989
Source: https://traffic.megaphone.fm/TTSAA3808177194.mp3?updated=1778178131

HTML Markdown JSON

Apr 30, 2026 · not_requested

399: Hair-raising trial results, and Servier’s M&A wishlist

Duration seconds: 2486
Source: https://traffic.megaphone.fm/TTSAA7086068693.mp3?updated=1777578856

HTML Markdown JSON

Apr 23, 2026 · not_requested

398: A CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts

Duration seconds: 2270
Source: https://traffic.megaphone.fm/TTSAA6592352327.mp3?updated=1777409428

HTML Markdown JSON

Apr 16, 2026 · not_requested

397: A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment

Duration seconds: 2987
Source: https://traffic.megaphone.fm/TTSAA1479018226.mp3

HTML Markdown JSON

Apr 9, 2026 · not_requested

396: A new trick for old science, and biotech VCs' scrambled playbook

Duration seconds: 1932
Source: https://traffic.megaphone.fm/TTSAA5523666345.mp3?updated=1775766569

HTML Markdown JSON

Apr 2, 2026 · not_requested

395: Biotech investors' plea to Trump, and a busy M&A week

Duration seconds: 1918
Source: https://traffic.megaphone.fm/TTSAA6976080442.mp3?updated=1775158295

HTML Markdown JSON

Mar 26, 2026 · not_requested

394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy

Duration seconds: 1552
Source: https://traffic.megaphone.fm/TTSAA4484091091.mp3?updated=1774548496

HTML Markdown JSON

Mar 20, 2026 · not_requested

393: A conversation with the 'godfather' of biotech

Duration seconds: 2705
Source: https://traffic.megaphone.fm/TTSAA2542570165.mp3?updated=1774024042

HTML Markdown JSON

Mar 12, 2026 · not_requested

392: Epstein's pal attempts a biotech comeback, and Prasad exits the FDA

Duration seconds: 1851
Source: https://traffic.megaphone.fm/TTSAA4013999142.mp3?updated=1773339038

HTML Markdown JSON

Mar 5, 2026 · not_requested

391: Breaching the IBD efficacy ceiling, and sham surgeries

Duration seconds: 1829
Source: https://traffic.megaphone.fm/TTSAA9607085727.mp3?updated=1772735911

HTML Markdown JSON

Feb 26, 2026 · not_requested

390: FDA turmoil, election intrigue, AI, and more

Duration seconds: 1960
Source: https://traffic.megaphone.fm/TTSAA2124962351.mp3?updated=1772132598

HTML Markdown JSON

Feb 19, 2026 · not_requested

389: Hims' Super Bowl fallout, and the FDA reverses course

Duration seconds: 2060
Source: https://traffic.megaphone.fm/TTSAA4438066659.mp3?updated=1771534813

HTML Markdown JSON

Feb 12, 2026 · not_requested

388: The FDA's refusal to review Moderna's mRNA flu vaccine

Duration seconds: 3084
Source: https://traffic.megaphone.fm/TTSAA7598338376.mp3?updated=1771001918

HTML Markdown JSON

Feb 5, 2026 · not_requested

387: Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s

Duration seconds: 1684
Source: https://traffic.megaphone.fm/TTSAA7740815504.mp3?updated=1770325297

HTML Markdown JSON

Feb 3, 2026 · not_requested

From Drug Story: Lipitor and Heart Disease

Duration seconds: 3696
Source: https://www.drugstory.co/p/episode-2-lipitor-and-heart-disease

HTML Markdown JSON

Jan 29, 2026 · not_requested

386: The high stakes for Huntington's patients

Duration seconds: 2499
Source: https://traffic.megaphone.fm/TTSAA4890848946.mp3?updated=1769722907

HTML Markdown JSON